8-K: Research Solutions Reports Record FY25 Net Income, EBITDA

Research Solutions, Inc. announced strong financial results for its fourth quarter and fiscal year ended June 30, 2025, driven by significant growth in platform revenue and improved profitability.

Summary

• For the fourth quarter of fiscal year 2025, platform revenue increased 21% to $5.2 million, and total revenue rose 3% to $12.4 million.
• Annual Recurring Revenue (ARR) grew 20% year-over-year to $20.9 million, comprising $14.2 million in B2B and $6.7 million in B2C recurring revenue.
• The company achieved a net income of $2.4 million, or $0.07 per diluted share, a significant improvement from a net loss of $2.8 million in the prior-year quarter.
• Adjusted EBITDA reached a record $1.6 million for the quarter, up 15%, and cash flow from operations was $2.3 million.
• For the full fiscal year 2025, platform revenue surged 36% to $19.0 million, contributing to a 10% increase in total revenue to $49.1 million.
• Fiscal year net income was $1.3 million, or $0.04 per diluted share, compared to a net loss of $3.8 million in fiscal 2024.
• Record Adjusted EBITDA of $5.3 million and record cash flow from operations of $7.0 million were reported for the full fiscal year.
• The company ended the fiscal year with $12.2 million in cash and cash equivalents.

Sentiment

Score: 9

Explanation: The filing indicates exceptionally strong financial performance, a successful strategic transition to a higher-margin business model, record profitability metrics, and a clear, positive outlook for continued growth, particularly in AI-powered solutions. The significant improvements across key financial indicators suggest robust operational health and future potential.

Positives

• Platform revenue increased 21% to $5.2 million in Q4 2025 and 36% to $19.0 million for FY2025, reflecting a successful strategic shift to SaaS and AI solutions.
• Annual Recurring Revenue (ARR) grew 20% year-over-year to $20.9 million, indicating strong recurring business growth.
• Total gross margin improved significantly, reaching 51% in Q4 2025 (up 450 basis points) and 49.3% for FY2025 (up 530 basis points), crossing 50% for the first time on a blended basis.
• Net income for Q4 2025 was $2.4 million ($0.07 per diluted share), a substantial turnaround from a $2.8 million net loss in Q4 2024, partly due to a $1.1 million favorable Scite earnout adjustment.
• Fiscal year 2025 net income was $1.3 million ($0.04 per diluted share), reversing a $3.8 million net loss in fiscal 2024.
• Adjusted EBITDA reached company records of $1.6 million in Q4 2025 (up 15%) and $5.3 million for FY2025 (up 134.8%).
• Cash flow from operations hit company records of $2.3 million in Q4 2025 and $7.0 million for FY2025.
• Cash and cash equivalents increased to $12.2 million at the end of FY2025, up from $6.1 million in FY2024.
• Platform revenue now represents nearly 40% of total revenue for FY2025, up from 31% in FY2024, demonstrating successful business model transition.
• The AI-based Scite product's growth rate is over 40%, indicating strong performance in a key strategic area.
• Proactive adjustment of the Scite earnout payout structure offered more cash and reduced dilution to current shareholders.

Negatives

• Transaction revenue decreased 7.7% to $7.3 million in Q4 2025 and 1.8% to $30.1 million for FY2025, primarily due to lower paid order volume.
• The transaction active customer count decreased by 60 customers (4.3%) in Q4 2025 compared to the prior-year quarter, totaling 1,338 customers.

Risks

• No new specific risks were detailed in this filing. General forward-looking statement risks were noted, referring to factors described in the company's most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q.

Future Outlook

Management remains focused on improving its 'Rule of 40 goal,' with a slight bias towards increased growth over profitability to create long-term value for shareholders. The company continues to actively pursue additional opportunities that enhance, complement, and strengthen its current product offerings, particularly in AI capabilities.

Management Comments

• "Fiscal 2025 reflects a year of significant progress in our ongoing SaaS software and AI solution set transition, with our platform revenue now representing nearly 40% of total revenue for the year compared to 31% in fiscal 2024."
• "As expected, this strategic shift and continued focus on recurring revenue has also translated into meaningful increases in gross margin, Adjusted EBITDA and operating cash flow."
• "Following the final earnout calculation for Scite, we proactively adjusted the payout structure, offering more cash and reducing dilution to current shareholders."
• "We remain focused on improving on our Rule of 40 goal, with a slight bias towards increased growth versus profitability, which in turn should create long-term value for our shareholders."
• "In addition, we used the Scite acquisition to help build out the AI capabilities in our product set and we continue to actively pursue additional opportunities that enhance, complement and strengthen our current product offerings."
• "The growth rate of our AI-based Scite product is over 40%, which I view as a good indication that we are on the right track."
• "Lastly, from a cash and Adjusted EBITDA perspective, we are better positioned than we ever have been to execute on these opportunities."

Industry Context

Research Solutions, Inc.'s strong performance, particularly in platform revenue and AI-based product growth, aligns with broader industry trends favoring SaaS models and AI integration in specialized software sectors. The successful transition to a higher-margin, recurring revenue model positions the company well within the evolving research workflow and scientific content market.

Comparison to Industry Standards

• The company is focused on improving its 'Rule of 40 goal,' a common benchmark in the SaaS industry where a company's revenue growth rate and EBITDA margin should sum to 40% or more. Management indicates a bias towards growth over profitability in this pursuit.
• No specific comparable companies, projects, or results were listed in the filing for direct comparison.

Stakeholder Impact

• Shareholders: Positive impact due to significant improvements in net income, Adjusted EBITDA, and cash flow, along with management's focus on long-term value creation and reduced dilution from the Scite earnout adjustment.
• Customers: Benefit from the company's continued investment in AI-powered research workflow platforms and enhanced product offerings, leading to more efficient scientific discovery.

Next Steps

• Continue improving on the 'Rule of 40 goal,' with a bias towards increased growth versus profitability.
• Actively pursue additional opportunities that enhance, complement, and strengthen current product offerings, especially in AI capabilities.
• Host a conference call on September 18, 2025, to discuss results and answer questions.

Key Dates

Recommendation

The company has demonstrated exceptional financial performance, successfully executing a strategic shift towards a high-margin, recurring platform revenue model. Record net income, Adjusted EBITDA, and cash flow from operations, coupled with strong ARR growth and a clear focus on AI-driven expansion, indicate robust underlying business health and significant future growth potential. The positive trajectory and management's commitment to long-term shareholder value make this an attractive investment opportunity.

Keywords

AI-powered research workflow, SaaS, Platform revenue, Annual Recurring Revenue, Adjusted EBITDA, Net income, Cash flow from operations, Scite, B2B, B2C, Financial results, SEC filing, Research Solutions